Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
60,279,508
-
Shares change
-
-669,407
-
Total reported value, excl. options
-
$5,644,577,484
-
Value change
-
-$61,738,785
-
Put/Call ratio
-
112%
-
Number of buys
-
69
-
Number of sells
-
74
-
Price
-
$93.64
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q3 2023
As of 30 Sep 2023 Ascendis Pharma A/S - ADR (ASND) had 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 60,279,508 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Artisan Partners Limited Partnership, FMR LLC, T. Rowe Price Investment Management, Inc., JANUS HENDERSON GROUP PLC, WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital International Investors, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 157 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.